How do you compound your topical JAK inhibitors like tofacitinib or ruxolitinib?

Featuring Seemal Desai, MD | Education Advisor |

Clinical Assistant Professor 
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

| Published September 29, 2021

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved